Safety and efficacy of adapalene gel 0.1% in acne vulgaris: Results of a post-marketing surveillance study

Indian Journal of Dermatology, Venereology and Leprology

Volumn 69, Issue 4, 2003, Pages 277-280

  Sanjana, Percy H ^a,b  

^a Galderma India Pvt Ltd   (India)

^b Galderma India Pvt Ltd   (India)

Author keywords

Acne vulgaris; Adapalene; Indian skin; Safety and efficacy; Treatment

Indexed keywords

ADAFERIN; ADAPALENE; ANTI ACNE AGENT; BENZOYL PEROXIDE; RETINOID;

ACNE VULGARIS; ADULT; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PATIENT COMPLIANCE; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRURITUS; RISK ASSESSMENT; SIDE EFFECT; SKIN IRRITATION; XEROSIS;

EID: 33646484918     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Brogden RN, Goa KE. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 1997;53:511-9.
2. Michel S, Jomard A, Demarchez M. Pharmacology of adapalene. Br J Dermatol 1998;139:3-7.
3. Martin B, Meunier C, Montels D, Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol 1998;139:8-11.
4. Allec J, Chatelus A, Wagner N. Skin distribution and pharmaceutical aspects of adapalene gel. J Am Acad Dermatol 1997;36:S119-25.
5. Bershad S, Poulin YP, Berson DS, et al. Topical retinoids in the treatment of acne vulgaris. Cutis 1999;64:8-20.
6. Grosshans E, Marks R, Mascaro JM, Torras H, Meynadier J, Alirezai M, et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 1998;139:26-33.
7. Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol 1998;139:48-56.
8. Cunliffe WJ, Danby FW, Dunlap F, Gold MH, Gratton D, Greenspan A. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. Eur J Dermatol 2002;12:350-4.
9. Caron D, Sorba V, Clucas A, Verschoore M. Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments. J Am Acad Dermatol 1997;36:S113-5.
10. Leyden JJ. Adapalene in clinical practice. Cutis 2001;68:7-9.
11. Baker M, Tuley M, Busdiecker FL, Herndon JH Jr, Slayton RM. Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting. Cutis 2001;68:41-7.
12. Toole JW, Lockhart L, Potrebka J, Bowman JP, Novack GD. Comparative irritancy study among retinoid creams and gels. J Cutan Med Surg 1999;3:298-301.
13. Egan N, Loesche C, Baker M. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis 2001;68:20-4.
14. Ioannides D, Reigopoulos D, Katsambas A. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial. Br J Dermatol 2002;147:523-7.
15. Zhu XJ, Tu P, Zhen J, Duan YQ. Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients. Cutis 2001;68:55-9.
16. Tu P, Li GQ, Zhu XJ, Zheng J, Wong WZ. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China. J Eur Acad Dermatol Venereol 2001;15:31-6.
17. Jacyk WK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis 2001;68:48-54.
18. Jacyk WK. Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol 2001;15:37-42.